LeMaitre Vascular (LMAT) Senior Vice President, Trent G. Kamke, recently exercised and sold 2,625 shares of common stock, generating approximately $285,000. This transaction, reported through an SEC Form 4 filing, indicates a 28.22% reduction in Kamke’s direct equity exposure, as his holdings dropped from about 9,000 to 6,677 shares. The sale aligns with Kamke’s recent trading patterns, suggesting a consistent approach to liquidating vested options while maintaining compliance with company policies.
This insider transaction comes amid a strong performance for LeMaitre, with shares up over 30% year-to-date and a reported 16% increase in fourth-quarter sales, reaching $64.5 million. The company also announced a 25% dividend increase, reflecting its robust financial health and commitment to returning value to shareholders. With management forecasting a 12% sales growth and a 22% rise in adjusted earnings for the year, the outlook remains positive.
For investors, Kamke’s sale appears more about personal liquidity than a lack of confidence in the company’s prospects, reinforcing the narrative of a well-performing stock with a solid growth trajectory.
Source: fool.com